Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic [0.03%]
新冠病毒感染或接种疫苗期间/之后的头痛可能是原发性的也可能是继发性的，可能是急性发作的也可能是慢性存在的
Josef Finsterer,Sounira Mehri
Josef Finsterer
What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries [0.03%]
阿尔茨海默病是什么？对二十世纪和二十一世纪分类学观点的分析
Nicolas Villain,Robin Michalon
Nicolas Villain
Background: Recent US proposals suggest defining Alzheimer's disease (AD) based on β-amyloidosis alone. This sparked debates that echoed historical ones about the significance of brain lesions and clinical phenotype. ...
Rick Dersch,Gabriel Torbahn,Sebastian Rauer
Rick Dersch
Background and purpose: Residual symptoms after treatment of Lyme disease, sometimes called post-treatment Lyme disease symptoms (PTLDs), are a matter of ongoing controversy. To guide treatment recommendations, a systemat...
Simon Fandler-Höfler,Benedetta Storti
Simon Fandler-Höfler
Lower serum uric acid to serum creatinine ratio as a predictor of poor functional outcome after mechanical thrombectomy in acute ischaemic stroke [0.03%]
急性缺血性卒中机械取栓术后功能预后不良的血尿酸水平与肌酐水平比值较低为预测因素
Jinghan Xu,Xin Jiang,Qian Liu et al.
Jinghan Xu et al.
Background and purpose: The ratio of serum uric acid (SUA) to serum creatinine (SCr), representing normalized SUA for renal function, is associated with functional outcome in acute ischaemic stroke (AIS) patients. However...
Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study [0.03%]
阿维糖苷酶alfa治疗进行性加重的晚发型庞贝病患者的真实世界疗效研究：一项法国队列研究一年后的结果
Céline Tard,Françoise Bouhour,Maud Michaud et al.
Céline Tard et al.
Introduction: Late-onset Pompe disease (LOPD) is characterized by a progressive myopathy resulting from a deficiency of acid α-glucosidase enzyme activity. Enzyme replacement therapy has been shown to be effective, but l...
Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group [0.03%]
原发性线粒体疾病患者的癫痫管理：InterERN工作组共识陈述
Michelangelo Mancuso,Maria T Papadopoulou,Yi Shiau Ng et al.
Michelangelo Mancuso et al.
Background and purpose: Primary mitochondrial diseases (PMDs) are common inborn errors of energy metabolism, with an estimated prevalence of one in 4300. These disorders typically affect tissues with high energy requireme...
Real-world persistence of multiple sclerosis disease-modifying therapies [0.03%]
多发性硬化症疾病修正疗法的现实世界的持久性
Emma C Tallantyre,Ruth Dobson,Joseph L J Froud et al.
Emma C Tallantyre et al.
Background and purpose: Treatment persistence is the continuation of therapy over time. It reflects a combination of treatment efficacy and tolerability. We aimed to describe real-world rates of persistence on disease-mod...
Bernhard J Steinhoff
Bernhard J Steinhoff
Association of diabetes mellitus with dementia- and non-dementia-related mortality amongst women: a secondary competing risks analysis of the California Teachers Study [0.03%]
糖尿病与女性痴呆症和非痴呆症相关死亡率之间的关联——加州教师研究的二次竞争风险分析
Cathleen Morgan,Bradon Annegers,Matthew K Taylor et al.
Cathleen Morgan et al.
Background and purpose: The prevalence of dementia is rapidly increasing. Attempts to further understand modifiable risk factors such as diabetes mellitus (DM) are urgently needed to inform public health policies for prev...